197 related articles for article (PubMed ID: 24134128)
21. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
22. Splanchnic hemodynamics in cirrhotic patients with esophageal varices and gastrointestinal bleeding.
Lebrec D; Kotelanski B; Cohn JN
Gastroenterology; 1976 Jun; 70(6):1108-11. PubMed ID: 1083820
[TBL] [Abstract][Full Text] [Related]
23. The gut does not contribute to systemic ammonia release in humans without portosystemic shunting.
van de Poll MC; Ligthart-Melis GC; Olde Damink SW; van Leeuwen PA; Beets-Tan RG; Deutz NE; Wigmore SJ; Soeters PB; Dejong CH
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G760-5. PubMed ID: 18703642
[TBL] [Abstract][Full Text] [Related]
24. Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure.
Ytrebø LM; Sen S; Rose C; Ten Have GA; Davies NA; Hodges S; Nedredal GI; Romero-Gomez M; Williams R; Revhaug A; Jalan R; Deutz NE
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G373-81. PubMed ID: 16782695
[TBL] [Abstract][Full Text] [Related]
25. A simple method for the quantification of portosystemic shunting (PSS) in patients with portal hypertension.
Bödvarsson A; Verdegaal WP; Slaats EH; Geraedts AA; Kehrer DF; Silberbusch J
Neth J Med; 1993 Dec; 43(5-6):204-9. PubMed ID: 8107925
[TBL] [Abstract][Full Text] [Related]
26. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
Lotterer E; Wengert A; Fleig WE
Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between hemodynamic parameters of the portal circulation in cirrhotic patients].
Bretagne JF; Bourguet P; Morisot D; Duvauferrier R; Darnault P; Gastard J
Gastroenterol Clin Biol; 1985 Oct; 9(10):674-8. PubMed ID: 4065489
[TBL] [Abstract][Full Text] [Related]
28. Severe hyperammonaemia in adults not explained by liver disease.
Walker V
Ann Clin Biochem; 2012 May; 49(Pt 3):214-28. PubMed ID: 22349554
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].
Eisenburg J; Krumpoch B; Grunst J; Weinzierl M; Munte A; Schmidt S; Magerl W; Schauer S
Fortschr Med; 1972 Aug; 90(24):837-48. PubMed ID: 4639347
[No Abstract] [Full Text] [Related]
31. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
[TBL] [Abstract][Full Text] [Related]
32. [Animal experiments on portal collateral circulation and on hyperammonemia].
Leonhardt H; Bungert HJ; Wolff Cv
Z Exp Chir; 1972; 5(4):249-53. PubMed ID: 4680982
[No Abstract] [Full Text] [Related]
33. Hepatic arterial buffer response in patients with advanced cirrhosis.
Gülberg V; Haag K; Rössle M; Gerbes AL
Hepatology; 2002 Mar; 35(3):630-4. PubMed ID: 11870377
[TBL] [Abstract][Full Text] [Related]
34. Rectal 13N-ammonia test (13N-liver/heart ratio), hepatic sinusoidal pressure and prevailing portal flow direction in cirrhosis of the liver.
Hazenberg HJ; Gips CH; Beekhuis H; Kruizinga K
Acta Hepatogastroenterol (Stuttg); 1976; 23(5):319-27. PubMed ID: 983660
[TBL] [Abstract][Full Text] [Related]
35. Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia.
Mardini H; Smith FE; Record CO; Blamire AM
J Hepatol; 2011 Jun; 54(6):1154-60. PubMed ID: 21145802
[TBL] [Abstract][Full Text] [Related]
36. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
Conn HO; Rössle M; Levy L; Glocker FX
Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
[TBL] [Abstract][Full Text] [Related]
37. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
[TBL] [Abstract][Full Text] [Related]
38. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
39. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
40. Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosis.
Olde Damink SW; Dejong CH; Jalan R
Aliment Pharmacol Ther; 2009 Apr; 29(8):801-10. PubMed ID: 19183148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
